Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer

por Dong, Huaying, Hu, Jianguo, Zou, Kejian, Ye, Mulin, Chen, Yuanwen, Wu, Chengyi, Chen, Xin, Han, Mingli
Publicado 2019

Correction to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer

por Dong, Huaying, Hu, Jianguo, Zou, Kejian, Ye, Mulin, Chen, Yuanwen, Wu, Chengyi, Chen, Xin, Han, Mingli
Publicado 2021

Retraction Note to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cance...

por Dong, Huaying, Hu, Jianguo, Zou, Kejian, Ye, Mulin, Chen, Yuanwen, Wu, Chengyi, Chen, Xin, Han, Mingli
Publicado 2022

Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer

por Dong, Huaying, Wang, Wei, Chen, Ru, Zhang, Yu, Zou, Kejian, Ye, Mulin, He, Xionghui, Zhang, Fan, Han, Jing
Publicado 2018

Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer

por Dong, Huaying, Wang, Wei, Chen, Ru, Zhang, Yu, Zou, Kejian, Ye, Mulin, He, Xionghui, Zhang, Fan, Han, Jing
Publicado 2022

Long non‐coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation

por Dong, Huaying, Wang, Wei, Mo, Shaowei, Liu, Qiang, Chen, Xin, Chen, Ru, Zhang, Yu, Zou, Kejian, Ye, Mulin, He, Xionghui, Zhang, Fan, Han, Jing, Hu, Jianguo
Publicado 2018

Retraction Note: Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer

por Han, Mingli, Hu, Jianguo, Lu, Pengwei, Cao, Hui, Yu, Chao, Li, Xiangke, Qian, Xueke, Yang, Xue, Yang, Yunqing, Han, Na, Dou, Dongwei, Zhang, Fan, Ye, Mulin, Yang, Changcheng, Gu, Yuanting, Dong, Huaying
Publicado 2023

Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer

por Han, Mingli, Hu, Jianguo, Lu, Pengwei, Cao, Hui, Yu, Chao, Li, Xiangke, Qian, Xueke, Yang, Xue, Yang, Yunqing, Han, Na, Dou, Dongwei, Zhang, Fan, Ye, Mulin, Yang, Changcheng, Gu, Yuanting, Dong, Huaying
Publicado 2020